This conference has been deferred to 2023 due to the ongoing impact of the COVID-19 pandemic. Please check back soon for the 2023 schedule.
Cancer nanotechnology is the application of nanoscale materials towards the investigation, diagnosis, and treatment of cancer. The unique properties of nanomaterials and their interactions with cells in and around the tumor microenvironment are enabling new opportunities in cancer biology and therapy. The breadth of applications of nanotechnology towards cancer continues to expand with exciting new developments in combination treatments, cancer immunotherapy, molecular detection, and imaging. The 2021 Cancer Nanotechnology Gordon Research Conference (GRC) will provide a unique forum where scientists at every stage of their career can share unpublished, innovative cancer research made possible by the use of nanotechnology. This meeting will particularly focus on two ends of the spectrum in cancer research: deepening our fundamental understanding of the interactions of nanomaterials with tumors and the in vivo environment, and translation of cancer nanotechnology out of the lab and into the clinic. The conference will bring together a lively group of exceptional scientists in order to (i) share cutting-edge research in cancer nanotechnology by experts representing the whole spectrum of life sciences, exact sciences, engineering, and medicine; (ii) foster discussion, exchange of ideas, and promote collaborations, and (iii) enhance the training and development of young scientists while promoting diversity. By bringing together individuals spanning diverse disciplines from cancer biology to chemical engineering, we will gain new insights for harnessing nanotechnology in the fight against cancer. This meeting will continue the successful trend of the last several years to include a Gordon Research Seminar designed by and aimed at the education of junior investigators in the field and will include activities aimed at professional development for scientists across all career stages.